Article
Pharmacogenomics to Drive COVID-19 Therapy for Best Outcome in a Low Resource Setting
2020-09-02
Abstract excerpt
Corona virus disease 2019 (COVID-19) has taken the world by storm with global infectivity and mortality of 3.5%. Since there is no specific treatment for COVID-19, several drugs have been repurposed to combat infection, these include drugs like anti-malarial – chloroquine, hydroxychloroquine, anti- diarrheal– loperamide and antipsychotic-promazine, which have been considered to be effective inhibitors as of viral...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 30ddc0f7-cbc2-55c7-9593-7f9855e87ae1
- DOI
- 10.21467/preprints.214
